Sign in

Mark Tryniski

Director at Bancorp
Board

About Mark E. Tryniski

Independent director at The Bancorp, Inc. (TBBK) since 2024; age 64; Audit Committee Chair and member of the Compensation and Talent Committee. Retired President & CEO of Community Bank System, Inc. (2006–2023), continued on its board until May 2024; previously COO and CFO (2003–2006) and a partner at PricewaterhouseCoopers LLP. Designated by the Board as an “audit committee financial expert” under SEC rules, reflecting deep finance, accounting, risk management, and governance credentials .

Past Roles

OrganizationRoleTenureCommittees/Impact
Community Bank System, Inc.President & CEO; previously COO & CFOCEO 2006–2023; COO/CFO 2003–2006Led a public financial holding company; extensive finance, risk, regulatory and governance experience .
PricewaterhouseCoopers LLPPartnerNot disclosedBroad industry experience with extensive financial services exposure .
CONMED Corporation (NYSE: CNMD)Director; Chairman of the BoardDirector 2007–2022; Chairman 2014–2020Public company board leadership; governance and oversight experience .
New York Bankers AssociationDirectorOver fifteen yearsSector advocacy and regulatory engagement experience .

External Roles

OrganizationRoleStatus
Pursuit BDC (formerly New York Business Development Corporation)DirectorSince 2010 .

Board Governance

  • Independence: Determined independent under Nasdaq standards; committees composed exclusively of independent directors .
  • Committee assignments: Audit (Chair); Compensation and Talent (member). Audit met 6x in 2024; Compensation and Talent met 4x .
  • Attendance and engagement: Board held 6 meetings in 2024; director nominees had ~98% Board attendance and 100% committee attendance; each nominee who served on a committee attended all their committee meetings in 2024 .
  • Audit Committee expertise: Board determined Tryniski qualifies as an “audit committee financial expert” .
  • Leadership structure: Independent Board Chair; executive sessions without management at Board and committee levels .

Fixed Compensation

Board-wide director pay structure (2024):

  • Annual cash retainer: $75,000; Audit Committee Chair fee: $10,000; other committee chairs: $5,000; Audit Committee members: $5,000; other committee members: $2,500 each; Non-executive Board Chair additional $70,000; annual RSU grant market value $90,000; directors may elect to take some/all cash in stock .

Mark Tryniski – 2024 director compensation:

Component2024 Amount (USD)
Fees earned or paid in cash$7,083
Stock awards (grant-date fair value)$165,000 (closing price $32.32 on May 30, 2024)
Total$172,083

Notes:

  • Upon election in May 2024, Tryniski elected to take all annual cash retainer in stock awards; directors joining post-annual meeting receive pro-rata cash fees and do not receive pro-rata equity grants .

Performance Compensation

  • Structure: Directors receive time-based RSUs; no director performance metrics disclosed (no PSUs, no options for directors). Annual director RSU grant sized at $90,000 market value; grant-date closing price on May 30, 2024 was $32.32; Tryniski’s stock awards totaled $165,000 reflecting RSUs and elected stock-in-lieu of cash retainer .
  • Clawbacks, hedging/pledging: Company prohibits hedging and pledging of Company stock; maintains executive clawbacks (mandatory for restatements; discretionary for misconduct) enhancing overall governance posture .

Other Directorships & Interlocks

CompanyTypeRoleCurrent/FormerPotential Interlock/Conflict
Community Bank System, Inc.PublicDirectorFormer (served through May 2024)None disclosed with TBBK .
CONMED CorporationPublicDirector; ChairmanFormerNone disclosed with TBBK .
Pursuit BDCBDC (not specified as public)DirectorCurrentNone disclosed with TBBK .
New York Bankers AssociationTrade AssociationDirectorFormerSector oversight; no transaction interlock disclosed .
  • TBBK biography lists “Other Public Boards: None” for current roles, indicating no current public company interlocks .

Expertise & Qualifications

  • Finance and accounting; banking industry operations; risk management; regulatory oversight; corporate governance; strategic planning and M&A experience .
  • Audit Committee financial expert designation (SEC definition) .

Equity Ownership

MetricValue
Beneficial ownership (shares)10,105 shares
Percent of class<1% (based on 47,954,218 outstanding shares as of April 2, 2025)
Pledged sharesProhibited by Insider Trading Policy (hedging and pledging banned)
Ownership guidelinesDirectors must own ≥2× annual fees; newly appointed directors have up to 5 years to comply; all directors and executives are currently in compliance .

Governance Assessment

  • Strengths

    • Independent director; Audit Chair; designated financial expert—supports robust financial reporting oversight .
    • Dual service on Audit and Compensation & Talent provides cross-functional oversight; Compensation Committee uses independent consultant; strong clawback and anti-hedging policies .
    • Attendance and engagement strong (Board ~98%; committees 100% among nominees; per-committee attendance affirmed for nominees serving in 2024) .
    • Director equity alignment: elected to receive cash retainer in stock; annual RSUs standard—enhances skin-in-the-game .
    • No related-party transactions attributed to Tryniski; overall related-party lending noted as ordinary-course, Regulation O-compliant .
  • Watch items

    • No disclosed performance-based director equity (RSUs are time-based); alignment depends on share price rather than explicit targets .
    • As Audit Chair, oversight of 2024 auditor transition (Grant Thornton to Crowe) is material; no disagreements/reportable events disclosed, but continue monitoring audit quality and fees .
  • Signals of investor confidence

    • Say-on-pay support ~96% at 2024 annual meeting, reflecting broader governance and compensation program acceptance (contextual to TBBK; not director-specific) .

Director Compensation – Structure Reference (Board-Wide)

ComponentAnnual Amount
Cash retainer (independent directors)$75,000
Audit Committee Chair fee$10,000
Other committee chair fee$5,000
Audit Committee member fee$5,000
Other committee member fee (per committee)$2,500
Additional fee – Board Chair (non-executive)$70,000
Annual RSU grant (each independent director)$90,000 grant-date market value
Election to take cash in stockPermitted (some or all)

Committee Engagement (TBBK)

  • Audit Committee: Tryniski (Chair) with regular oversight of financial reporting, internal/external audit; audit committee independence and SEC Rule 10A-3 compliance affirmed .
  • Compensation & Talent Committee: Member; committee independence affirmed; Tryniski signed the Compensation and Talent Committee Report .

Attendance & Meetings (2024)

BodyMeetings HeldAttendance Indicator
Board of Directors6Nominees: ~98% Board attendance; all directors then serving attended 2024 annual meeting except one (not Tryniski); nominees serving on committees attended all their committee meetings .
Audit Committee6Committee independence; heightened standards met .
Compensation & Talent Committee4Committee independence; enhanced standards met .

Related Party & Conflicts

  • No related party transactions disclosed involving Tryniski. Ordinary-course lending to related parties ($6.9 million outstanding as of Dec 31, 2024) made on market terms, Regulation O-compliant; de minimis legal services paid to Duane Morris ($4,800) assessed for independence (unrelated to Tryniski) .
  • Insider Trading Policy prohibits hedging and pledging; stock ownership guidelines enforce alignment .

RED FLAGS

  • None explicitly disclosed for Tryniski (no pledging, no related-party exposure, no low attendance). Continue monitoring:
    • Auditor transition dynamics as Audit Chair (ensure ongoing audit quality, fee reasonableness) .
    • Any future overlapping directorships with TBBK counterparties; currently “Other Public Boards: None” .

Overall, Tryniski’s profile indicates strong governance alignment: independent status, audit financial expertise, high engagement, equity-based alignment, and absence of disclosed conflicts—supportive of board effectiveness and investor confidence .